Efficacy and safety of apremilast in patients with moderate‐to‐severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study

Detalles Bibliográficos
Autores principales: Van Voorhees, A.S., Stein Gold, L., Lebwohl, M., Strober, B., Sofen, H., Papp, K., Bagel, J., Zhang, Z., Paris, M., Wang, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518877/
https://www.ncbi.nlm.nih.gov/pubmed/33763874
http://dx.doi.org/10.1111/bjd.20083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518877/
https://www.ncbi.nlm.nih.gov/pubmed/33763874
http://dx.doi.org/10.1111/bjd.20083

Ejemplares similares